# Correction: Hsa_circ_0021727 (circ-CD44) promotes ESCC progression by targeting miR-23b-5p to activate the TAB1/NFκB pathway

**Authors:** Fan Meng, Xiaokang Zhang, Yanting Wang, Jie Lin, Yulin Tang, Guisheng Zhang, Binqiang Qiu, Xingdu Zeng, Weiyou Liu, Xin He

PMC · DOI: 10.1038/s41419-025-07437-y · Cell Death & Disease · 2025-02-27

## Full-text entities

- **Genes:** TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1) [NCBI Gene 10454] {aka 3'-Tab1, MAP3K7IP1}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}
- **Diseases:** ESCC (MESH:D004938)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11868364/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11868364/full.md

---
Source: https://tomesphere.com/paper/PMC11868364